Page last updated: 2024-11-01

ondansetron and Pityriasis Rosea

ondansetron has been researched along with Pityriasis Rosea in 1 studies

Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.

Pityriasis Rosea: A mild exanthematous inflammation of unknown etiology. It is characterized by the presence of salmon-colored maculopapular lesions. The most striking feature is the arrangement of the lesions such that the long axis is parallel to the lines of cleavage. The eruptions are usually generalized, affecting chiefly the trunk, and the course is often self-limiting.

Research Excerpts

ExcerptRelevanceReference
" The rash started 2 days after the patient had started taking ondansetron 8 mg for alleviation of moderate-to-severe nausea and vomiting of pregnancy."7.88Pityriasis rosea-like eruption associated with ondansetron use in pregnancy. ( Alame, MM; Chamsy, DJ; Zaraket, H, 2018)
" The rash started 2 days after the patient had started taking ondansetron 8 mg for alleviation of moderate-to-severe nausea and vomiting of pregnancy."3.88Pityriasis rosea-like eruption associated with ondansetron use in pregnancy. ( Alame, MM; Chamsy, DJ; Zaraket, H, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alame, MM1
Chamsy, DJ1
Zaraket, H1

Other Studies

1 other study available for ondansetron and Pityriasis Rosea

ArticleYear
Pityriasis rosea-like eruption associated with ondansetron use in pregnancy.
    British journal of clinical pharmacology, 2018, Volume: 84, Issue:5

    Topics: Adult; Antiemetics; Female; Humans; Ondansetron; Pityriasis Rosea; Pregnancy; Pregnancy Complication

2018